Page last updated: 2024-10-15

7-deaza-2'-deoxyguanosine

Description

7-deaza-2'-deoxyguanosine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135411006
CHEBI ID195565
SCHEMBL ID1737223
MeSH IDM0132378

Synonyms (27)

Synonym
2'-deoxy-7-deazaguanosine
2-amino-7-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-3h-pyrrolo[2,3-d]pyrimidin-4-one
86392-75-8
7-deaza-2'-deoxyguanosine
2-amino-7-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-pyrrolo[2,3-d]pyrimidin-4-one
CHEBI:195565
2-amino-7-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1h-pyrrolo[2,3-d]pyrimidin-4-one
7668fg8w4u ,
4h-pyrrolo(2,3-d)pyrimidin-4-one, 2-amino-7-(2-deoxy-beta-d-erythro-pentofuranosyl)-1,7-dihydro-
unii-7668fg8w4u
SCHEMBL1737223
J-700372
7-deaza-2'-dg
AC-32282
CS-0100854
2'-deoxy-7-carbaguanosine
4h-pyrrolo(2,3-d)pyrimidin-4-one, 2-amino-7-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-1,7-dihydro-
2-amino-7-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3h-pyrrolo[2,3-d]pyrimidin-4(7h)-one
BCP18415
2-amino-7-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1h-pyrrolo[2,3-d]pyrimidin-4(7h)-one
CS-16586
2-amino-7-(2-deoxy-beta-d-erythro-pentofuranosyl-3,7- dihydropyrrolo[2,3-d]pyrimidin-4-one
Q27266458
DTXSID501006781
7-(2-deoxypentofuranosyl)-2-imino-2,7-dihydro-1h-pyrrolo[2,3-d]pyrimidin-4-ol
AKOS037651342
7-deaza-2 -deoxyguanosine
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
pyrrolopyrimidine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (21.74)18.7374
1990's2 (8.70)18.2507
2000's11 (47.83)29.6817
2010's5 (21.74)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]